The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients: A Randomized, Placebo-Controlled, 52-Week Clinical Trial
Phase of Trial: Phase III
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- 18 May 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 18 May 2010 Actual patient number (17) added as reported by ClinicalTrials.gov.
- 23 Jan 2009 Status changed from active, no longer recruiting to completed, based on information from ClinicalTrials.gov.